Compare Indoco Remedies with CCL INTERNATIONAL - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs CCL INTERNATIONAL - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES CCL INTERNATIONAL INDOCO REMEDIES/
CCL INTERNATIONAL
 
P/E (TTM) x 120.8 44.6 271.1% View Chart
P/BV x 2.0 2.4 83.1% View Chart
Dividend Yield % 0.7 0.5 126.3%  

Financials

 INDOCO REMEDIES   CCL INTERNATIONAL
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
CCL INTERNATIONAL
Mar-15
INDOCO REMEDIES/
CCL INTERNATIONAL
5-Yr Chart
Click to enlarge
High Rs317487 65.2%   
Low Rs178266 66.9%   
Sales per share (Unadj.) Rs113.19.8 1,150.1%  
Earnings per share (Unadj.) Rs4.50.1 4,173.5%  
Cash flow per share (Unadj.) Rs11.80.2 4,914.2%  
Dividends per share (Unadj.) Rs1.000.05 2,000.0%  
Dividend yield (eoy) %0.40 3,039.8%  
Book value per share (Unadj.) Rs73.23.8 1,905.9%  
Shares outstanding (eoy) m92.1595.96 96.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.238.3 5.7%   
Avg P/E ratio x55.53,518.4 1.6%  
P/CF ratio (eoy) x21.01,566.3 1.3%  
Price / Book Value ratio x3.498.0 3.5%  
Dividend payout %22.446.7 47.9%   
Avg Mkt Cap Rs m22,83036,134 63.2%   
No. of employees `0005.5NA-   
Total wages/salary Rs m2,20911 21,039.0%   
Avg. sales/employee Rs Th1,910.1NM-  
Avg. wages/employee Rs Th405.0NM-  
Avg. net profit/employee Rs Th75.5NM-  
INCOME DATA
Net Sales Rs m10,419943 1,104.5%  
Other income Rs m476 808.6%   
Total revenues Rs m10,466949 1,102.6%   
Gross profit Rs m1,34935 3,833.2%  
Depreciation Rs m67713 5,289.8%   
Interest Rs m23513 1,794.7%   
Profit before tax Rs m48415 3,205.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m725 1,499.0%   
Profit after tax Rs m41210 4,007.8%  
Gross profit margin %12.93.7 347.1%  
Effective tax rate %15.032.0 46.8%   
Net profit margin %4.01.1 362.9%  
BALANCE SHEET DATA
Current assets Rs m5,373315 1,707.6%   
Current liabilities Rs m4,157224 1,852.5%   
Net working cap to sales %11.79.6 122.0%  
Current ratio x1.31.4 92.2%  
Inventory Days Days6858 116.5%  
Debtors Days Days736 1,191.0%  
Net fixed assets Rs m6,244212 2,939.8%   
Share capital Rs m184192 96.0%   
"Free" reserves Rs m6,566177 3,711.4%   
Net worth Rs m6,750369 1,830.2%   
Long term debt Rs m1,23334 3,669.0%   
Total assets Rs m12,363632 1,956.1%  
Interest coverage x3.12.2 142.1%   
Debt to equity ratio x0.20.1 200.5%  
Sales to assets ratio x0.81.5 56.5%   
Return on assets %5.23.7 141.5%  
Return on equity %6.12.8 219.0%  
Return on capital %9.07.0 128.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,7620-   
Fx outflow Rs m1,1430-   
Net fx Rs m2,6190-   
CASH FLOW
From Operations Rs m1,22714 8,522.2%  
From Investments Rs m-1,36014 -10,074.8%  
From Financial Activity Rs m-388-1 64,616.7%  
Net Cashflow Rs m-52127 -1,907.0%  

Share Holding

Indian Promoters % 59.2 44.6 132.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 0.0 -  
FIIs % 6.0 0.2 3,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 55.3 40.5%  
Shareholders   12,805 1,958 654.0%  
Pledged promoter(s) holding % 0.0 2.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   CHOLAMANDALAM INVEST.  NESCO  KITEX GARMENTS  COMPACT DISC  TATA INVESTMENT  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

CCL INTERNATIONAL Announces Quarterly Results (3QFY19); Net Profit Down 75.9% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, CCL INTERNATIONAL has posted a net profit of Rs 1 m (down 75.9% YoY). Sales on the other hand came in at Rs 97 m (down 5.1% YoY). Read on for a complete analysis of CCL INTERNATIONAL's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Oct 22, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS